Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Intellego: Expert Advice for Choosing and Using UV-C Disinfection Systems for Your Facility

“Deploying UV-C technology requires meeting facility needs and ensuring they know how to use it and validate it that it’s working properly.” Disinfection is at the forefront of everyone’s mind in a pandemic. As a result, most facilities need a portfolio of tools to support this, with UV-C being one of those. But how can…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Intellego: Expert Advice for Choosing and Using UV-C Disinfection Systems for Your Facility

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

“Deploying UV-C technology requires meeting facility needs and ensuring they know how to use it and validate it that it’s working properly.”

Disinfection is at the forefront of everyone’s mind in a pandemic. As a result, most facilities need a portfolio of tools to support this, with UV-C being one of those. But how can organizations implement it and ensure it’s working? In this discussion, host Daniel Litwin spoke to two subject matter experts, Wendy Brady-Walling, Director of Global Marketing, Intellego Technologies, and Christine Gallo, CEO, Gallo Medical Company and IP Program.

Gallo, already in the medical industry, became a bigger advocate for infection prevention and disinfection after a family member’s health battle. “I realized we have to do better, and that’s what led me to add UV-C to the toolbox to help with this,” she said.

Gallo’s objective now is to partner with facilities to help them find funding to acquire and deploy UV-C disinfection systems and ensure it’s working by using UV-C dosimeters, which provide visual validation of disinfection. She noted that dosimeters are included in the purchase of the UV-C equipment and that her team trains staff on how to use them.

Brady-Walling discussed the many delivery systems of UV-C, from mobile towers to ceiling mounts to autonomous robots. “Pre-COVID, UV-C disinfection systems were considered ‘nice to have.’ Now they’re a ‘need to have.’ That’s why we’re focused on educating industries about its availability, safety, efficacy, and efficiency.”

The pandemic also meant using UV-C in new spaces, including restaurants, airports, gyms, and office buildings. In the healthcare setting, UV-C was in use in operating rooms. “They are using it in patient rooms prior to staff cleaning, so it’s safer for them. We just deployed it at a cancer center.”

Brady-Walling added, “They love the technology and the visual evidence from the dosimeter that it was a successful disinfection.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Real-time radiation dose tracking is moving from badges to live dashboards in procedure rooms

Real-time radiation dose tracking is moving from badges to live dashboards in procedure rooms

Radiation Detection Company has introduced a live radiation dose tracking system called Radiant that updates every 0.2 seconds. GE HealthCare has developed browser-based imaging access for hospitals, transforming how radiation monitoring is managed in procedure rooms. This advancement in live dashboards is enhancing real-time monitoring capabilities in healthcare facilities.

  • 01Radiation Detection Company's Radiant updates radiation dose data every 0.2 seconds.
  • 02GE HealthCare has developed browser-based imaging access for better hospital management.
  • 03Live dashboards are transforming radiation monitoring in procedure rooms.

Aug 30, 2026

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft has introduced a 60% discount for its Dragon Copilot, prompting a reevaluation of how digital health ROI is measured. The initiative targets rural hospitals, while European efforts like EDiHTA highlight the need for a consistent method to price technology evidence. This shift reflects a broader trend in healthcare towards data-driven decision-making and cost assessment.

  • 01Microsoft offers a 60% discount for Dragon Copilot aimed at rural hospitals.
  • 02There's a growing need for a standardized approach to pricing technology evidence in healthcare.
  • 03The European EDiHTA initiative exemplifies the trend of data-driven evaluation in digital health.

Aug 30, 2026

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512